News Releases

May 2018

May 2, 2018 5/2/2018 TRINTELLIX® (vortioxetine) Prescribing Information Now Includes New Data Showing Improvement in Processing Speed, an Important Aspect of Cognitive Function in Acute Major Depressive Disorder (MDD)

March 2018

March 12, 2018 3/12/2018 Takeda Announces Results from Uloric® (febuxostat) Cardiovascular Outcomes Trial

February 2018

February 6, 2018 2/6/2018 Takeda Announces Publication of Study Utilizing State-of-the-Art Modeling to Better Understand Optimal Treatment Positioning for Patients with Ulcerative Colitis

January 2018

January 23, 2018 1/23/2018 Takeda Utilizes Social Media Analysis and Survey in a Study to Better Understand Patient Preferences When Seeking Treatment for Inflammatory Bowel Disease

January 5, 2018 1/5/2018 Takeda Announces Intention to Acquire TiGenix

November 2017

November 17, 2017 11/17/2017 Takeda and Cognition Kit Present Results from Digital Wearable Technology Study in patients with Major Depressive Disorder (MDD)

November 17, 2017 11/17/2017 The Boston Globe Names Takeda Pharmaceuticals U.S.A., Inc. a Top Place to Work for 2017

November 10, 2017 11/10/2017 The Chicago Tribune Names Takeda Pharmaceuticals U.S.A., Inc. A Workplace Achiever of the Chicago Area 2017 Top Workplaces Award